Literature DB >> 27581286

RNAi Screening of Leukemia Cells Using Electroporation.

Anupriya Agarwal1,2, Jeffrey W Tyner3,4.   

Abstract

RNAi-mediated screening has been an integral tool for biological discovery for the past 15 years. A variety of approaches have been employed for implementation of this technique, including pooled, depletion/enrichment screening with lentiviral shRNAs, and segregated screening of panels of individual siRNAs. The latter approach of siRNA panel screening requires efficient methods for transfection of siRNAs into the target cells. In the case of suspension leukemia cell lines and primary cells, many of the conventional transfection techniques using liposomal or calcium phosphate-mediated transfection provide very low efficiency. In this case, electroporation is the only transfection technique offering high efficiency transfection of siRNAs into the target leukemia cells. Here, we describe methods for optimization and implementation of siRNA electroporation into leukemia cell lines and primary patient specimens, and we further offer suggested electroporation settings for some commonly used leukemia cell lines.

Entities:  

Keywords:  Electroporation; Leukemia; siRNA screening

Mesh:

Year:  2016        PMID: 27581286      PMCID: PMC5240908          DOI: 10.1007/978-1-4939-6337-9_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

Review 1.  Unlocking the potential of the human genome with RNA interference.

Authors:  Gregory J Hannon; John J Rossi
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  RNA interference microarrays: high-throughput loss-of-function genetics in mammalian cells.

Authors:  Jose M Silva; Hana Mizuno; Amy Brady; Robert Lucito; Gregory J Hannon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-14       Impact factor: 11.205

3.  A genetic screen for candidate tumor suppressors identifies REST.

Authors:  Thomas F Westbrook; Eric S Martin; Michael R Schlabach; Yumei Leng; Anthony C Liang; Bin Feng; Jean J Zhao; Thomas M Roberts; Gail Mandel; Gregory J Hannon; Ronald A Depinho; Lynda Chin; Stephen J Elledge
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

4.  Crosstalk between ROR1 and the Pre-B cell receptor promotes survival of t(1;19) acute lymphoblastic leukemia.

Authors:  Vincent T Bicocca; Bill H Chang; Behzad Kharabi Masouleh; Markus Muschen; Marc M Loriaux; Brian J Druker; Jeffrey W Tyner
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

5.  TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia.

Authors:  Takaomi Sanda; Jeffrey W Tyner; Alejandro Gutierrez; Vu N Ngo; Jason Glover; Bill H Chang; Arla Yost; Wenxue Ma; Angela G Fleischman; Wenjun Zhou; Yandan Yang; Maria Kleppe; Yebin Ahn; Jessica Tatarek; Michelle A Kelliher; Donna S Neuberg; Ross L Levine; Richard Moriggl; Mathias Müller; Nathanael S Gray; Catriona H M Jamieson; Andrew P Weng; Louis M Staudt; Brian J Druker; A Thomas Look
Journal:  Cancer Discov       Date:  2013-03-07       Impact factor: 39.397

6.  Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen.

Authors:  Lloyd T Lam; R Eric Davis; Vu N Ngo; Georg Lenz; George Wright; Weihong Xu; Hong Zhao; Xin Yu; Lenny Dang; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

7.  Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model.

Authors:  Anka Bric; Cornelius Miething; Carl Uli Bialucha; Claudio Scuoppo; Lars Zender; Alexander Krasnitz; Zhenyu Xuan; Johannes Zuber; Michael Wigler; James Hicks; Richard W McCombie; Michael T Hemann; Gregory J Hannon; Scott Powers; Scott W Lowe
Journal:  Cancer Cell       Date:  2009-10-06       Impact factor: 31.743

8.  A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal.

Authors:  Guang Hu; Jonghwan Kim; Qikai Xu; Yumei Leng; Stuart H Orkin; Stephen J Elledge
Journal:  Genes Dev       Date:  2009-04-01       Impact factor: 11.361

9.  A resource for large-scale RNA-interference-based screens in mammals.

Authors:  Patrick J Paddison; Jose M Silva; Douglas S Conklin; Mike Schlabach; Mamie Li; Shola Aruleba; Vivekanand Balija; Andy O'Shaughnessy; Lidia Gnoj; Kim Scobie; Kenneth Chang; Thomas Westbrook; Michele Cleary; Ravi Sachidanandam; W Richard McCombie; Stephen J Elledge; Gregory J Hannon
Journal:  Nature       Date:  2004-03-25       Impact factor: 49.962

10.  A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.

Authors:  Ji Luo; Michael J Emanuele; Danan Li; Chad J Creighton; Michael R Schlabach; Thomas F Westbrook; Kwok-Kin Wong; Stephen J Elledge
Journal:  Cell       Date:  2009-05-29       Impact factor: 41.582

View more
  2 in total

1.  RNAi Transfection Optimized in Primary Naïve B Cells for the Targeted Analysis of Human Plasma Cell Differentiation.

Authors:  Tiffany Shih; Saurav De; Betsy J Barnes
Journal:  Front Immunol       Date:  2019-07-23       Impact factor: 7.561

2.  LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma.

Authors:  Lillian R Klug; Amber E Bannon; Nathalie Javidi-Sharifi; Ajia Town; William H Fleming; Judy K VanSlyke; Linda S Musil; Jonathan A Fletcher; Jeffrey W Tyner; Michael C Heinrich
Journal:  Oncogene       Date:  2018-09-21       Impact factor: 8.756

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.